Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma
- PMID: 17409425
- DOI: 10.1158/0008-5472.CAN-06-3312
Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma
Abstract
Mutations in the BRAF serine/threonine kinase gene are frequently found in cutaneous melanomas. Activation of hypoxia inducible factor-1alpha (HIF-1alpha) in response to both hypoxic stress and oncogenic signals has important implications in cancer development and progression. Here, we report that mutant BRAF(V600E) increases HIF-1alpha expression in melanoma cells. Our microarray profiling data in 35 melanoma and melanocyte cell lines showed that HIF-1alpha gene expression was significantly increased in melanomas harboring BRAF(V600E) mutation. Stable suppression of mutant BRAF(V600E) or both wild-type and mutant BRAF(V600E) by RNA interference in melanoma cells resulted in significantly decreased HIF-1alpha expression. Knockdown of mutant BRAF(V600E) induced significant reduction of cell survival and proliferation under hypoxic conditions, whereas knockdown of both wild-type and mutant BRAF(V600E) resulted in further reduction. The effects of BRAF knockdown can be rescued by reintroducing BRAF(V600E) into tumor cells. Transfection of BRAF(V600E) into melanoma cells with wild-type BRAF induced significantly more hypoxic tolerance. Knockdown of HIF-1alpha in melanoma cells resulted in decreased cell survival under hypoxic conditions. Pharmacologic inhibition of BRAF by BAY 43-9006 also resulted in decreased HIF-1alpha expression. Although HIF-1alpha translational rate was not changed, the protein was less stable in BRAF knockdown cells. In additional, von Hippel-Lindau protein expression was significantly increased in BRAF knockdown cells. Our data show for the first time that BRAF(V600E) mutation increases HIF-1alpha expression and melanoma cell survival under hypoxic conditions and suggest that effects of the oncogenic V600E BRAF mutation may be partially mediated through the HIF-1alpha pathway.
Similar articles
-
Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.Pancreatology. 2012 Mar-Apr;12(2):170-8. doi: 10.1016/j.pan.2012.02.015. Epub 2012 Mar 2. Pancreatology. 2012. PMID: 22487528
-
Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.Pancreas. 2008 Mar;36(2):178-86. doi: 10.1097/MPA.0b013e31815929fe. Pancreas. 2008. PMID: 18376310
-
[Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].Ai Zheng. 2005 May;24(5):531-5. Ai Zheng. 2005. PMID: 15890092 Chinese.
-
Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma.Biochem Pharmacol. 2011 Aug 1;82(3):201-9. doi: 10.1016/j.bcp.2011.05.015. Epub 2011 May 25. Biochem Pharmacol. 2011. PMID: 21635872 Free PMC article. Review.
-
Braf V600E mutation in melanoma: translational current scenario.Clin Transl Oncol. 2016 Sep;18(9):863-71. doi: 10.1007/s12094-015-1469-6. Epub 2016 Jan 29. Clin Transl Oncol. 2016. PMID: 26825657 Review.
Cited by
-
HIF1α and HIF2α independently activate SRC to promote melanoma metastases.J Clin Invest. 2013 May;123(5):2078-93. doi: 10.1172/JCI66715. Epub 2013 Apr 8. J Clin Invest. 2013. PMID: 23563312 Free PMC article.
-
The Complex Role of Autophagy in Melanoma Evolution: New Perspectives From Mouse Models.Front Oncol. 2020 Jan 10;9:1506. doi: 10.3389/fonc.2019.01506. eCollection 2019. Front Oncol. 2020. PMID: 31998652 Free PMC article. Review.
-
Hif-1α Inhibitors Could Successfully Inhibit the Progression of Differentiated Thyroid Cancer in Vitro.Pharmaceuticals (Basel). 2020 Aug 24;13(9):208. doi: 10.3390/ph13090208. Pharmaceuticals (Basel). 2020. PMID: 32847004 Free PMC article.
-
Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicity.Nat Commun. 2024 Jan 20;15(1):633. doi: 10.1038/s41467-024-44778-2. Nat Commun. 2024. PMID: 38245503 Free PMC article.
-
Erythropoietin receptor contributes to melanoma cell survival in vivo.Oncogene. 2012 Mar 29;31(13):1649-60. doi: 10.1038/onc.2011.366. Epub 2011 Aug 22. Oncogene. 2012. PMID: 21860424 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials